Melatonin is a natural hormone that your body produces every night. Your pineal gland, a pea-sized structure deep in your brain, makes it from the amino acid tryptophan through a four-step chemical conversion. However, the melatonin in most supplements is not natural in the same sense. Nearly all commercial melatonin is manufactured through chemical synthesis in a lab.
How Your Body Makes Melatonin
Your pineal gland builds melatonin from tryptophan, an amino acid you get from protein-rich foods. The conversion happens in four steps: tryptophan is first converted into 5-hydroxytryptophan, which is then converted into serotonin. Serotonin is the main precursor. From there, two more chemical reactions transform serotonin into melatonin.
This process ramps up when darkness falls. Specialized cells in your eyes detect fading light and signal the pineal gland to start production. Melatonin levels peak in the middle of the night and drop off toward morning, which is why it’s often called the “sleep hormone,” though its actual role is more like a darkness signal that tells your body what time it is.
Blue light in the 446 to 477 nanometer range, the kind emitted by phone screens, tablets, and LED lighting, is particularly effective at suppressing this natural production. Research on blue LEDs has shown a clear dose-dependent relationship: the brighter the blue light exposure at night, the more your melatonin levels drop.
What’s in Melatonin Supplements
Virtually all melatonin sold as supplements is synthetic, created through chemical synthesis rather than extracted from animals or plants. Early melatonin for research was sourced from animal pineal glands and urine, but those methods were abandoned because of the risk of viral transmission. Chemical synthesis replaced them and remains the standard today.
The synthetic molecule is chemically identical to what your pineal gland produces. So while the source isn’t “natural” in the way many consumers imagine, the end product is the same compound. That said, the manufacturing process itself raises some concerns. One common synthesis route starts from tryptophan derivatives and has been linked to toxic by-products that caused a serious condition called eosinophilia myalgia syndrome. Other routes use starting materials with their own toxicity questions. The purity of the final product depends entirely on how well these by-products are removed.
There is growing interest in plant-derived melatonin, sometimes labeled “phytomelatonin.” Plants do produce melatonin naturally, but concentrations are extremely low, typically in the range of nanograms to micrograms per gram of plant tissue. Extracting enough for a supplement dose from plants alone is difficult and expensive, so most products on the shelf remain synthetically produced even when marketing suggests otherwise.
Label Accuracy Is a Real Problem
Because melatonin is classified as a dietary supplement in the United States rather than a drug, it doesn’t go through the same manufacturing and testing standards as prescription medications. A Canadian study that tested commercial melatonin products found that actual melatonin content ranged from 83% less than what the label claimed to 478% more. Some pills contained nearly five times the advertised dose, while others had almost none.
The same study also detected serotonin, a different neurochemical, in some of the supplements tested. This kind of variability means two bottles of “3 mg melatonin” from different brands could deliver wildly different amounts. If you’ve ever felt that melatonin “doesn’t work” or that it makes you groggy, inconsistent dosing could be part of the explanation.
How Much Actually Reaches Your System
Even setting aside label accuracy, your body absorbs oral melatonin inconsistently. Research published in the New England Journal of Medicine found that only about 33% of an oral dose makes it into your bloodstream on average, with a range from as low as 10% to as high as 56% depending on the person. Your liver breaks down a large portion before it ever circulates. This means two people taking the same pill can end up with very different blood levels of melatonin.
Does Taking Supplements Shut Down Natural Production?
One common worry is that supplementing melatonin will cause your body to stop making its own. The evidence so far is reassuring on this point. Research on chronic melatonin use has found that exogenous melatonin does not appear to reduce your body’s own production. Rebound insomnia, where sleep gets worse after stopping a sleep aid, has not been reported with melatonin. Withdrawal symptoms haven’t been observed either.
This distinguishes melatonin from many other sleep-related substances. Your pineal gland doesn’t seem to “learn” to produce less just because you’re supplementing.
Foods That Contain Natural Melatonin
If you’d prefer to get melatonin from whole food sources, several foods contain measurable amounts. Cranberries are among the richest sources studied, with one variety (Vaccinium macrocarpon) containing roughly 96 micrograms per gram of dried weight. Tart cherries, tomatoes, grapes, and certain nuts like pistachios and walnuts also contain melatonin, though concentrations vary widely depending on growing conditions.
To put these numbers in perspective, a typical melatonin supplement contains 1,000 to 5,000 micrograms (1 to 5 mg). You’d need to eat an impractical amount of any single food to match a supplement dose. Still, dietary melatonin from a varied diet contributes to your overall levels, and some researchers believe the combination of melatonin with other nutrients in whole foods may offer benefits that isolated supplements don’t.
The Bottom Line on “Natural”
Melatonin the molecule is completely natural. Your body has been making it every night of your life. But the melatonin in the bottle on your nightstand is almost certainly synthesized in a factory from chemical precursors. The final molecule is identical to what your pineal gland produces, so “synthetic” doesn’t automatically mean harmful or inferior. The real concerns with supplements are practical ones: inconsistent dosing, poor label accuracy, variable absorption, and limited regulatory oversight in the U.S. market.